Postmortem mRNA expression patterns in left ventricular myocardial tissues and their implications for forensic

Molecules and Cells
|March 20, 2014
PubMed

Insights

Sudden cardiac death (SCD) diagnosis is improved by analyzing myocardial mRNA. Hemoglobin (HBA1/2, HBB) and pyruvate dehydrogenase kinase 4 (PDK4) mRNA levels serve as molecular signatures for fatal cardiac dysfunction.

Area of Science:

  • Forensic Pathology
  • Molecular Biology
  • Cardiology

Background:

  • Sudden cardiac death (SCD) is a leading cause of mortality in developed nations, often stemming from heart disorders.
  • Diagnosing SCD postmortem can be challenging due to limited histological evidence.
  • Myocardial ischemia, primarily from coronary artery disease, is a common cause of SCD.

Purpose of the Study:

  • To identify distinct postmortem mRNA expression patterns in the heart for diagnosing SCD.
  • To evaluate specific mRNA markers, including hemoglobin and pyruvate dehydrogenase kinase 4, for their utility in forensic investigations of cardiac death.

Main Methods:

  • Analysis of postmortem mRNA expression levels of Hba1/2, Hbb, and Pdk4 in the left ventricular free wall.
  • Comparison of mRNA expression between sudden cardiac death subjects and controls with non-cardiac causes of death.
  • Correlation of mRNA expression with cardiac pathology, including acute myocardial infarction and ischemic heart disease.

Main Results:

  • Hemoglobin A1/2 and B (Hba1/2, Hbb) mRNA levels were elevated in SCD cases compared to controls.
  • Pyruvate dehydrogenase kinase 4 (Pdk4) mRNA levels were decreased in SCD subjects.
  • These distinct mRNA expression patterns were observed even in cases without apparent pathological signs of heart injury.

Conclusions:

  • Altered myocardial Hba1/2, Hbb, and Pdk4 mRNA expression patterns can serve as molecular signatures for fatal cardiac dysfunction.
  • These molecular signatures can aid in forensically implicating SCD as the primary cause of death.
  • The findings offer a novel approach to improve postmortem diagnosis in cases of suspected sudden cardiac death.

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
1.2K
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
645
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
805